Meta-analysis: Anticholinergics, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.springerlink.com/index/pdf/10.1111/j.1525-1497.2006.00507.x
Reference71 articles.
1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–46.
2. Agusti AG. COPD, a multicomponent disease: implications for management. Respir Med. 2005;99:670–82.
3. McCrory DC, Brown CD, Gelfand SE, Bach PB. Management of acute exacerbations of COPD A summary and appraisal of published evidence. Chest. 2001;119:1190–209.
4. U.S. Department of Health and Human Services. COPD data fact sheet. NIH publication No. 03-5229. 2003.
5. Gan WQ, Man SF, Sin DD. Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med. 2005;5:3.
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap;Respiratory Research;2022-12-20
2. Current and Emerging Therapies in Chronic Obstructive Pulmonary Disease;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26
3. Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis;BMC Pulmonary Medicine;2017-12
4. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid;Annals of Pharmacotherapy;2017-07-05
5. One‐year mortality associated with COPD treatment: a comparison of tiotropium and long‐acting beta2‐agonists in three Italian regions: results from the OUTPUL study;Pharmacoepidemiology and Drug Safety;2016-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3